IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP II, LLC

Q3 2022 Holdings

Filed 2022-11-03 | 1 holdings | $1.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Jounce Therapeutics, Inc.(JNCEEUR)COM481116101$1.3K572,829100.0%